FindTrial
Sign In

The Effect of Jade Screen Powder on IgE and Eosinophils in Childhood Asthma of stable situation

The Effect of Jade Screen Powder on IgE and Eosinophils in Childhood Asthma of stable situation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-13004324
Enrollment
Unknown
Registered
2013-12-15
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood asthma

Interventions

adrenal corticosteroids:Budesonide
Montelukast:Montelukast
adrenal corticosteroids & JSP:Budesonide & JSP
Montelukast & JSP:Montelukast & JSP
Jade Screen Powder (JSP):JSP

Sponsors

Department of Pediatrics, Shanghai TCM-Integrated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Bronchial asthma, according with CMA guidline of children astnma in 2008; (2) In stable situation; (3) In maintainance treatment period of western medicine; (4) IgE increase in serum and/or eosinophilia in peripheral blood; (5) The children aged from 4 to 12, no restrict gender; (6) Signed the informed consultaion file.

Exclusion criteria

Exclusion criteria: (1) Accompany with other respiratory chronic disease; (2) Acute attack of asthma; (3) patients have had take other TCM herbs; (4) self-disrupted taking Jade Screen Powder; (5) May be not cooperation in the follow-up and examine; (6) Over and under age limitation.

Design outcomes

Primary

MeasureTime frame
IgE;Eosinophilic granulocyte count;Cytokines (IL-4/IL-5/IL-9/IL-17);—

Countries

China

Contacts

Public ContactCHAO-BIN SHEN

Department of Pediatrics, Shanghai TCM-Integrated Hospital

sbsys1303@aliyun.com+86 21-65415910-6359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026